# A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer

Source: https://onco.cc/trials/nct06526624/  
OnCo record `nct06526624` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of HS-20093 in lung cancer, run by Hansoh BioMedical R&D Company, not yet recruiting.

## Summary

A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung Cancer is a phase 3, randomised interventional study registered as NCT06526624 by Hansoh BioMedical R&D Company, with a registry enrolment figure of 406 participants, started 2024-09-30 and due to reach its primary completion in 2027-11-30. Interventions recorded: HS-20093. Conditions listed: Limited-stage Small-cell Lung Cancer. Primary outcome: Progression-free survival (PFS) According to RECIST v1.1 by Independent Review Committee (IRC); Overall survival (OS). Lung eligibility wording from the registry: "Patients with limited-stage SCLC who are deemed unsuitable for surgery or decline surgery". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06526624
- Phase: 3
- Setting: ARTEMIS-009: A Phase 3, Randomized, Controlled, Multi-center, Open-label Study of HS-20093 Versus Active Surveillance As Consolidation Therapy After Chemoradiotherapy in Subjects With Limited-Stage Small Cell Lung Cancer
- Sponsor: Hansoh BioMedical R&D Company
- Enrolled: 406

## Sources

- ClinicalTrials.gov NCT06526624: https://clinicaltrials.gov/study/NCT06526624

## Connected records

- cancers: [Limited-stage small-cell lung cancer](https://onco.cc/cancers/limited-stage-sclc/)
- technologies: [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/)
- drugs: [HS-20093](https://onco.cc/drugs/hs-20093/)
- companies: [Hansoh Pharmaceutical](https://onco.cc/companies/hansoh-pharma/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06526624.json